I will not be able to listen to the CC, but if GC Investor is...

I will not be able to listen to the CC, but if GC Investor is correct that Kazia is raising funds @ .40 someone please ask this question. Why make this statement in your presser..."Before losing patent protection, temozolomide achieved peak sales in excess of US$ 1 billion
per annum, which provides an indication of the commercial opportunity associated with a
new treatment for glioblastoma." If you use some deductive reasoning, JG is inferring that GDC has the "potential" for a billion in annual sales.Then why dilute your existing holders at a 30 million AUD valuation? Let the market value rise before CR!!!